Zobrazeno 1 - 10
of 247
pro vyhledávání: '"Toshinori, Yamamoto"'
Autor:
John Broad, Nobuyuki Takahashi, Masaomi Tajimi, Masaki Sudo, Adam Góralczyk, Umesh Parampalli, Kesava Mannur, Toshinori Yamamoto, Gareth J. Sanger
Publikováno v:
Journal of Pharmacological Sciences, Vol 130, Iss 2, Pp 60-65 (2016)
The aim was to characterise RQ-00201894, a novel non-macrolide motilin agonist, using human recombinant receptors and then investigate its ability to facilitate cholinergic activity in human stomach. A reporter gene assay assessed motilin receptor fu
Externí odkaz:
https://doaj.org/article/f635d8a8c56549dfabfbcb812b73f3c9
Publikováno v:
BPB Reports. 5:125-132
Autor:
Masayuki Maeda, Toshinori Yamamoto, Moemi Fukuda, Mari Kogo, Tsutomu Kawasaki, Noriko Kohyama
Publikováno v:
The Showa University Journal of Medical Sciences. 33:55-64
Autor:
Hirokazu Honda, Yasuna Kobayashi, Shoko Onuma, Keigo Shibagaki, Toshitaka Yuza, Keiichi Hirao, Toshinori Yamamoto, Naohisa Tomosugi, Takanori Shibata
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0151601 (2016)
BACKGROUND:We aimed to identify associations between erythroferrone (ERFE), a regulator of hepcidin 25, and biomarkers of erythropoiesis and iron metabolism. We also aimed to determine the effects of erythropoiesis-stimulating agents (ESA), continuou
Externí odkaz:
https://doaj.org/article/f7d26c92fb50470bb0ad1364877e5f0e
Autor:
Satoko Handa, Erika Sugiyama, Yasuhisa Kato, Yoshiyuki Miyasaka, Akihiro Nakamura, Hitomi Yamamoto, Noriko Kohyama, Sachiko Tanaka, Tatsuya Kurihara, Mari Kogo, Toshinori Yamamoto
Publikováno v:
YAKUGAKU ZASSHI. 140:1441-1454
A requirement, which students must satisfy, for a diploma at the Showa University School of Pharmacy is the ability to "plan, practice, and assess pharmacotherapy". To continuously assess the ability of students to meet this requirement and to provid
Publikováno v:
YAKUGAKU ZASSHI. 139:1427-1434
Recently, a clinical study using a Chronic Liver Disease Questionnaire (CLDQ) showed that ledipasvir/sofosbuvir (LDV/SOF)-treated patients' QOL was more favorable than that of IFN/ribavirin (RBV)-treated patients. However, no study has reported QOL a
Publikováno v:
Eur J Hosp Pharm
OBJECTIVE: We investigated factors associated with a reduction in the quality of life and their OR of patients with chronic hepatitis C who underwent ledipasvir/sofosbuvir therapy. METHODS: The subjects were 141 outpatients who had undergone ledipasv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b16fadbb9d7bcc7c8e4cf3f937ebb38
https://europepmc.org/articles/PMC8640396/
https://europepmc.org/articles/PMC8640396/
Autor:
Tomotake Koizumi, Takeshi Aoki, Yasuna Kobayashi, Daisuke Yasuda, Yoshihiko Izumida, Zhenghao Jin, Nobukazu Nishino, Yoshinori Shimizu, Hirohisa Kato, Noriyuki Murai, Takashi Niiya, Yuta Enami, Keitaro Mitamura, Toshinori Yamamoto, Mitsuo Kusano
Publikováno v:
Cell Transplantation, Vol 16 (2007)
Transplantation of isolated hepatocytes has been proposed to compensate for essential functions lacking in liver failure or for genetic defects that alter a specific liver metabolic pathway. Hepatocyte utilization for these purposes would be facilita
Externí odkaz:
https://doaj.org/article/d745a6576fc2484eb3fb34de10e02e8f
Publikováno v:
Neuroscience Research. 125:46-53
Riluzole blocks persistent Na + current, inhibits generation of neuronal bursts and decreases glutamate-induced excitotoxicity. In previous studies of respiratory activity, riluzole suppressed inspiratory-related burst generation activity in rat slic
Publikováno v:
European Journal of Hospital Pharmacy; 2021 Special Issue, Vol. 28, pe29-e34, 6p